Researchers identify an immunomodulatory drug as a potential treatment for Parkinson’s disease
Astrocytes in the brains of Parkinson’s patients overexpress the inflammatory cytokine IL-6, which induces the death of dopaminergic neurons. The results have been obtained thanks to obtaining induced pluripotent stem cells from Parkinson’s patients.